FOI release

Freedom of Information responses from the MHRA - week commencing 27 June 2022

皇冠体育app Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 27 June 2022

From:
Medicines and Healthcare products Regulatory Agency
Published
27 March 2023

Documents

Freedom of Information request on the ingredients used in the COVID-19 vaccines (FOI 22/757)

HTML

Freedom of Information request on the summary of risk management plan for Sucralfate (FOI 22/753)

HTML

Freedom of Information request on the product Alemtuzumab (FOI 22/771)

HTML

Freedom of Information request on the temporary authorisation of the COVID-19 vaccines (FOI 22/742)

HTML

Details

皇冠体育app Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 27 June 2022

Updates to this page

Published 27 March 2023

Sign up for emails or print this page

Related content